We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$14.5B
AUM Growth
+$1.96B
Cap. Flow
+$582M
Cap. Flow %
4.02%
Top 10 Hldgs %
31.8%
Holding
146
New
31
Increased
52
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$319M
2
IMMU
Immunomedics Inc
IMMU
+$296M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$216M
4
NYT icon
New York Times
NYT
+$130M
5
HLT icon
Hilton Worldwide
HLT
+$129M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$456M
2
WUBA
58.com Inc
WUBA
+$268M
3
CRM icon
Salesforce
CRM
+$181M
4
QGEN icon
Qiagen
QGEN
+$123M
5
CZR
Caesars Entertainment Corporation
CZR
+$97.2M

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Communication Services 17.58%
3 Technology 8.21%
4 Financials 7.39%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVA
101
Inventiva
IVA
$1.13B
$6.23M 0.04%
+527,870
New +$6.05M
SVRA icon
102
Savara
SVRA
$1.19B
$4.85M 0.03%
4,452,086
-18,878
-0.4% -$32.3K
ARYBU
103
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$4.43M 0.03%
402,523
+2,523
+0.6% +$28.6K
ISEE
104
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.26M 0.03%
754,740
+4,740
+0.6% +$22.6K
ACIA
105
DELISTED
Acacia Communications Inc
ACIA
$4.04M 0.03%
+60,000
New +$4.07M
EQ icon
106
Equillium
EQ
$133M
$4.04M 0.03%
+700,000
New +$5.67M
DYN icon
107
Dyne Therapeutics
DYN
$4.9B
$4.04M 0.03%
+200,000
New +$4.39M
QTNT
108
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3.21M 0.02%
+15,625
New +$4.05M
CRDF icon
109
Cardiff Oncology
CRDF
$77.2M
$2.84M 0.02%
+200,000
New +$1.32M
FUSN
110
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.25M 0.02%
187,600
-62,400
-25% -$853K
BRMK.WS
111
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$2.06M 0.01%
7,174,613
– –
AMWL icon
112
American Well
AMWL
$230M
$1.33M 0.01%
+2,250
New +$1.19M
PAND
113
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$1.15M 0.01%
+100,000
New +$1.71M
GOL
114
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$524K ﹤0.01%
85,838
– –
AKBA icon
115
Akebia Therapeutics
AKBA
$252M
– –
-750,000
Closed -$10.2M
AMRN
116
Amarin Corp
AMRN
$303M
– –
-156,250
Closed -$21.6M
CRSP icon
117
CRISPR Therapeutics
CRSP
$5.17B
– –
-150,000
Closed -$11M
CTMX icon
118
CytomX Therapeutics
CTMX
$754M
– –
-148,952
Closed -$1.24M
FXI icon
119
PUT
iShares China Large-Cap ETF
FXI
$4.31B
– –
-562,500
Closed -$22.3M
GOSS icon
120
Gossamer Bio
GOSS
$87M
– –
-100,000
Closed -$1.3M
PPLI
121
People Inc
PPLI
$3.1B
– –
-7,889,525
Closed -$456M
KPTI icon
122
Karyopharm Therapeutics
KPTI
$48M
– –
-89,000
Closed -$25.3M
QGEN icon
123
Qiagen
QGEN
$8.72B
– –
-2,716,943
Closed -$123M
RNAM
124
DELISTED
Avidity Biosciences
RNAM
– –
-50,000
Closed -$1.41M
RPRX icon
125
Royalty Pharma
RPRX
$25.3B
– –
-275,000
Closed -$13.4M
2 3 4
5
6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Farallon Capital Management held 146 positions worth $14.5B, up 16% from $12.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management deployed $582M of net new capital in Q3 2020, opening 31 new positions and adding to 52 existing holdings. Its largest new stake was Boston Scientific: 8,275,919 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Salesforce, an estimated $181M trimmed.

  • Farallon Capital Management's largest Q3 2020 buy was Boston Scientific: 8,275,919 shares worth $316M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q3 2020, an estimated $216M increase.
  • Farallon Capital Management's biggest Q3 2020 reduction was Salesforce, cutting an estimated $181M.
  • Farallon Capital Management fully exited People Inc in Q3 2020, selling an estimated $456M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $14.5B portfolio in Q3 2020.
  • Farallon Capital Management opened 31 new positions and closed 24 in Q3 2020.
  • Farallon Capital Management's portfolio value rose 16% quarter-over-quarter to $14.5B.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.